Table 2.
Characteristic | CgA | P value | PP | P value | |
---|---|---|---|---|---|
Age | 0.313* | 0.081 | 0.376* | 0.049 | |
| |||||
Tumor size | −0.033* | 0.861 | 0.362* | 0.063 | |
| |||||
Tumor number | 0.126* | 0.500 | 0.125* | 0.535 | |
| |||||
Sex (Mean) (SD) |
Male | 31.6 (191.0) | 0.247 | 2631.4 (8191.2) | 0.260 |
Female | 70.7 (199.7) | 59.5 (242.1) | |||
| |||||
Tumor location (Mean) (SD) |
Head/neck | −39.8 (45.5) | 0.306 | 132.5 (197.3) | 0.268 |
Body/tail | 32.4 (153.4) | 1130.4 (5289.1) | |||
| |||||
Tumor functional status (Mean) (SD) |
F | 176.3 (274.7) | 0.059 | 2765.5 (8148.6) | 0.019 |
NF | 25.5 (158.1) | −15.0 (65.4) | |||
| |||||
AJCC stage (Mean) (SD) |
I | 19.9 (155.1) | 0.420 | 72.6 (330.8) | 0.175 |
II | 60.4 (171.6) | 99.2 (137.6) | |||
| |||||
LNM (Mean) (SD) |
Yes | 20.0 (80.6) | 0.500 | 107.8 (176.7) | 0.671 |
No | 20.0 (150.3) | 107.9 (321.0) | |||
| |||||
LVI (Mean) (SD) |
Yes | 14.0 (89.1) | 0.767 | 181.5 (128.0) | 0.120 |
No | 39.4 (168.0) | 67.8 (273.8) |
CgA=chromogranin A; PP=pancreatic polypeptide; PNETs=pancreatic neuroendocrine tumors; AJCC=American Joint Committee on Cancer; F=functioning; NF=non-functioning; LNM=lymph node metastases; LVI=lymphovascular invasion.
Spearman correlation